Phil Franchina, Author at American Parkinson Disease Association

GET IT ON WITH PARKINSEX

Posted on October 12, 2023October 12, 2023 by Phil Franchina

Parkinson’s disease can make it difficult for partners to maintain a healthy relationship, especially...see more when it comes to intimacy. Symptoms of PD can affect the well-being of your relationship, and a couple may grow apart physically and emotionally because of it. Although sexual intimacy can be challenging for many people […]

WHAT’S HAPPENING AT APDA

Posted on October 12, 2023October 12, 2023 by Phil Franchina

Tools for daily success Join us for our brand-new three-part web series, Thriving Through Occupational...see more Therapy, where we explore the world of occupational therapy (OT) and the many ways it can benefit people living with PD. Hosted by trained OT experts, we share practical knowledge and provide tips and tricks to […]

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

Posted on October 12, 2023October 12, 2023 by Phil Franchina

Q: Can travel affect PD symptoms? A: Yes, in several ways. First,...see more travel can be exhausting, especially when dealing with time changes — and that fatigue can make PD symptoms seem worse. In addition, timing of medication doses can be difficult to manage when you’re changing time zones […]

HOPE IN PROGRESS: NEW RESEARCH UNDERWAY

Posted on October 12, 2023October 12, 2023 by Phil Franchina

From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded...see more researchers launch cutting-edge studies With someone diagnosed with PD every six minutes, scientific research is critical as we push for better treatments and ultimately, a cure. Devoted to our search for answers, APDA recently awarded $1.975 […]

SAGE THERAPEUTICS CLINICAL RESEARCH

Posted on October 12, 2023October 12, 2023 by Phil Franchina

Clinical Research Study in Mild Cognitive Impairment associated with Parkinson’s Disease (PD-MCI) The PRECEDENT study...see more is evaluating an investigational treatment for cognitive deficits such as memory and attention in Parkinson’s. This phase 2 study is sponsored by Sage Therapeutics, Inc. and is recruiting people aged 50 to 75 years who are […]

APDA’s ParkinSex Triumphs with Three Prestigious Industry Awards; Celebrated for Redefining & Rebuilding Intimacy for People with Parkinson’s

Posted on October 11, 2023October 11, 2023 by Phil Franchina

American Parkinson Disease Association’s innovative resource for people with Parkinson’s takes home Titanium ‘Best In Show’ Award, among others...see more NEW YORK, NY, October 11, 2023 – At the MM+M Awards last week, the American Parkinson Disease Association (APDA) won three highly coveted awards for its unique ParkinSex resource which was launched earlier in 2023. APDA’s […]

UPDATE: The National Plan to End Parkinson’s

Posted on October 5, 2023October 5, 2023 by Phil Franchina

In 2022, the U.S. House of Representatives introduced the National Plan to End...see more Parkinson’s Act – the first-ever legislation in Congress focusing on curing and preventing Parkinson’s disease (PD) and ensuring quality care for those living with the disease. Unfortunately, the bill did not pass at that time, but […]

APDA supports groundbreaking research into Circular RNA and its role in brain health and disease

Posted on September 21, 2023September 21, 2023 by Phil Franchina

In a recently published...see more study, a team of researchers at Brigham and Women’s Hospital, spearheaded by Drs. Xianjun Dong and Clemens Scherzer, studied an under-explored type of RNA, called circular RNA (circRNA) and its relationship to brain disease. APDA is […]

Hope in Progress: American Parkinson Disease Association Supports Researchers With $1.975 Million in New Funding

Posted on September 7, 2023September 7, 2023 by Phil Franchina

From understanding levodopa induced dyskinesias to exploring environmental risk factors of PD, APDA-funded researchers pursue cutting-edge studies NEW YORK,...see more NY, September 7, 2023 – The American Parkinson Disease Association (APDA) has just awarded $1.975 million to support innovative Parkinson’s disease (PD) research for the 2023-2024 funding year. The funded research projects will delve into key […]

Diversity in Parkinson’s Disease Research Grant

Posted on September 4, 2023December 12, 2024 by Phil Franchina

Diversity in Parkinson’s Disease Research Grant: Academic Year 2025-2026 Letter of Intent due: Dec 16 at 5:00PM EST, 2024. Invitation...see more for full application: Early February 2025 Full Application due: April 2025 Award details One year grant up to a maximum of $75,000 will be awarded to research scientists (MD, MD/PhD, or PhD). The applicants will receive […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

GET IT ON WITH PARKINSEX

WHAT’S HAPPENING AT APDA

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

HOPE IN PROGRESS: NEW RESEARCH UNDERWAY

SAGE THERAPEUTICS CLINICAL RESEARCH

APDA’s ParkinSex Triumphs with Three Prestigious Industry Awards; Celebrated for Redefining & Rebuilding Intimacy for People with Parkinson’s

UPDATE: The National Plan to End Parkinson’s

APDA supports groundbreaking research into Circular RNA and its role in brain health and disease

Hope in Progress: American Parkinson Disease Association Supports Researchers With $1.975 Million in New Funding

Diversity in Parkinson’s Disease Research Grant

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!